Disease | Acute Necrotizing Encephalopathy (ANE) | |
---|
Inheritance | Autosomal dominant | |
Prevalence | “Acute necrotizing encephalopathy type 1 is likely a very rare condition, although its incidence is unknown. At least 59 cases of this condition have been reported in the scientific literature.” Source: MedlinePlus | |
Rapid or full curation? | | |
ClinGen / GenCC / BabySeq / HGMD / OMIM | ClinGen: This gene-disease association is not in ClinGen, although there is a curation for RANBP2 - Leigh syndrome. GenCC: BabySeq: Absent. HGMD: DM: Encephalopathy, acute necrotising DM?: Increased risk of neurodevelopmental disorder, Autism spectrum disorder, Miscarriage, Hypoplastic left heart syndrome, Atypical cerebral palsy, Primary biliary cholangitis. Congenital heart disease, Psychiatric disorder.
OMIM: {Encephalopathy, acute, infection-induced, 3, susceptibility to}, AD | |
Clinical Validity Scoring Notes and points | Variant/Case Evidence: RANBP2 c.1754C>T p.T585M REVEL: 0.178 2 alleles in GnomAD v4. PMID: 19118815: 35 unrelated families with clinical dx of ANE. This variant was identified in 9 of the families. Haplotype analysis was done and 7 families showed unique haplotypes, so only including those 7 families: PMID: 19811512: 9 yo Caucasian female with rapid-onset severe encephalopathy triggered by viral infections. MRI characteristic of ANE during both episodes. Mother had an episode of ‘encephalitis/polyneuritis’ after having a viral infection at the age of 19 years; she has had a foot drop since then. Variant identified in proband and mother, de novo in mother. Reported as c.1880C→T. 0.5 points (not counting mother since phenotype is unclear/unconfirmed)
PMID: 34377735: 9 month old female with seizure and 4 day hx of fever. EEG was consistent with encephalopathy. MRI suggestive of possible acute viral encephalitis. PMID: 37090838: Two Brazilian families with ANE and c.1754C > T (p.Thr585Met) (total 1 point) Family 1 (0.5 points) Family 2 (0.5 points)
PMID: 26923722 Patient P1, 10 month old boy with ANE confirmed on MRI. p.Thr585Met identified, inherited from healthy father. (0.5 points)
Other reports of this variant were present but not reviewed. From HGMD, PMIDs: 21945312, 25128471, 24321870, 25522933, 27591117, 28336122, 29741717, 29687329, 31589614, 30796099, 32760653, 33879512, 34059398, 33777149, 33761695, 34400285, 33726816, 35870896.
RANBP2 c.1958C>T p.Thr653Ile REVEL: 0.178 Absent from GnomAD. PMID: 19118815: PMID: 25170550 28 month old with ANE, confirmed on MRI. Older sister died at 6 months within 12 hours of presenting with fever and seizures. Father, paternal grandmother, and deceased sibling also had the same variant. “DNA from the index case was sequenced” - not sure what method was used, it seems like the authors may have looked at RANBP2 specifically. 0.5 points.
RANBP2 c.1966A>G p.Ile656Val REVEL: 0.306 1 allele in GnomAD v4 PMID: 19118815: PMID: 36029610 Identified p.I656V in the homozygous state in a patient with ANE on WES. A sibling was also affected but DNA could not be tested. Both sibs died before reaching 1 yo. Parents were heterozygous, unaffected. Consanguineous family. 0.5 points
RANBP2 c.2043G>C p.Trp681Cys REVEL: 0.460 Absent from GnomAD v4. PMID: 26923722
RANBP2 c.5249C>G Pro1750Arg RANBP2 c.1350A>T p.Leu450Phe Seen in 6 individuals in GnomAD v4. REVEL: 0.0570 PMID: 34377735: 6yo female with acute encephalopathy with seizures, MRI and EEG findings, and negative autoimmune, metabolic, infectious and toxic workup. Encephalopathy panel returned RANBP2 p.Leu450Phe, reported as a VUS. Not counting due to higher AF and very low REVEL score.
Segregation Evidence: RANBP2 c.1754C>T p.T585M REVEL: 0.178 2 alleles in GnomAD v4. PMID: 19118815: 35 unrelated families with clinical dx of ANE. 35 unrelated families with clinical dx of ANE. This variant was identified in 9 of the families. Haplotype analysis was done and 7 families showed unique haplotypes, so only including those 7 families: Descr. as c.1880C/T, p.Thr585Met. Familial cases (incomplete penetrance, phenocopies present - used calculator) (total 1 point) Family 586: 8 segregations (1 point) Family 102: 1 segregation (0 point) Family 112: 0 segregations (0 points) Family 105: 1 segregation (0 points) Family 670: 1 segregation (0 points) Family 690: 1 segregation (0 points) Family 119: 0 segregations (0 points)
PMID: 37090838: Two Brazilian families with ANE and c.1754C > T (p.Thr585Met) Searched for variants in RANBP2 specifically and identified this. (total: 0 points) Family 1 (0.5 points): 3 segregations (0 points) Family 2 (0.5 points): 0 segregations (0 points)
Variant/Case Evidence: 9 points (so far) Segregation Evidence: 1 point (so far) Case/Control Evidence: N/A Experimental Evidence: Source: | |
Clinical Validity Points Total | Source: | |
Clinical Validity Classification Expand |
---|
title | Classifications (pts) |
---|
| Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed |
| Source: | |
Molecular Mechanism Expand |
---|
| Loss of function Gain of function Dominant negative Unknown Other |
| Loss of function / Gain of function / Dominant Negative | |
Penetrance Expand |
---|
| Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) |
(list source/PMID) | ~40% Source: PMID: 19811512 | |
Age of Onset Expand |
---|
| Congenital Pediatric Adolescent Adulthood Late adulthood |
(list source/PMID) | | |
Severity Expand |
---|
| Embryonic lethal - presence of a pathogenic variant or variants is not compatible with life. The penetrance must be complete. Severe - presence of a pathogenic variant or variant(s) results in significantly reduced fitness. The penetrance must be complete or high. Moderate - significant morbidity or mortality due to clinical features, but fitness may not be reduced, or penetrance is reduced. Mild - Presence of a variant or variant(s) is not associated with reduced fitness, no significant morbidity or mortality, and/or penetrance is low. None - presence of a variant results in no phenotype. An example is recessive disorders in which no phenotype is reported in carriers. |
| | |
Clinical Features | Triggered by febrile viral illness, causing acute encephalopathy 1-3 days following the onset of the infection. This may include “deteriorating consciousness, with rapid progression to coma, and can be accompanied by seizures and focal neurologic deficits” (PMID: 32426208). Recurrent episodes are common. Sources: PMID: 32426208 | |
HPO Terms https://hpo.jax.org/app/ | | |
Gene SOPs & Notes | https://docs.google.com/document/d/1XY2_T3IJ7mtVPSrC6dCWmV2gqgqJ2p1laVBGZySK7vM/edit | |
Curation Summary Expand |
---|
| - The @GENE@ is associated with @inheritance pattern@ @condition@, which is characterized by @clinical features@ (PMIDs). - Variable expression or severity: The severity and expressivity of the disorder is highly variable, even within families. - If multiple conditions associated with the gene: It has also been associated with @inheritance pattern@ @condition@, which is characterized by @clinical features@ (PMIDs). - Limited evidence gene: The PCNA gene has been reported in individuals with early onset autosomal recessive ataxia (PMID: 33426167, 24911150), however, evidence supporting this gene-dIsease relationship is limited |
| | |
Case ID, Curator name, Date, Jira ticket link | Case ID: SDSM-8F Areesha Salman, 12/14/2023 | |